Analyst Price Targets — DBVT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 18, 2025 11:46 am | Andrew Fein | H.C. Wainwright | $40.00 | $22.55 | StreetInsider | DBV Technologies S.A (DBVT) PT Raised to $40 at H.C. Wainwright |
| December 17, 2025 1:10 pm | Kristen Kluska | Cantor Fitzgerald | $48.00 | $22.92 | TheFly | DBV Technologies price target raised to $48 from $42 at Cantor Fitzgerald |
| December 17, 2025 9:32 am | Yatin Suneja | Guggenheim | $51.00 | $17.98 | StreetInsider | DBV Technologies S.A (DBVT) PT Raised to $51 at Guggenheim |
| December 15, 2025 11:39 am | Andrew Fein | H.C. Wainwright | $35.00 | $19.11 | StreetInsider | DBV Technologies S.A (DBVT) PT Raised to $35 at H.C. Wainwright |
| December 14, 2025 11:55 pm | Kristen Kluska | Cantor Fitzgerald | $42.00 | $18.38 | TheFly | DBV Technologies initiated with an Overweight at Cantor Fitzgerald |
| December 3, 2025 11:12 am | — | Guggenheim | $35.00 | $12.90 | TheFly | DBV Technologies initiated with a Buy at Guggenheim |
| May 5, 2025 10:08 am | Andrew Fein | H.C. Wainwright | $16.00 | $9.25 | TheFly | DBV Technologies price target raised to $16 from $7 at H.C. Wainwright |
Latest News for DBVT
DBV Technologies S.A. (DBVT) reported positive Phase 3 VITESSE results for Viaskin Peanut, advancing toward blockbuster sales projections exceeding $2 billion. My model estimates Viaskin Peanut's U.S. peak sales at $1.25 billion, with global revenues potentially reaching $2.1 billion, assuming central penetration and duration metrics. Current DBVT market valuation (~$2 billion) implies either lower peak sales or…
DBV Technologies (DBVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The mean of analysts' price targets for DBV Technologies (DBVT) points to a 79% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
Shares of DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, one has given a hold recommendation, four have assigned a buy recommendation
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DBVT.
U.S. House Trading
No House trades found for DBVT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.